Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria.
History
On February 18, 2020, CARB-X awarded a $16.9 million grant to Lytica Therapeutics for a project to “develop antibacterial peptides with broad activity against multidrug-resistant bacteria.”1) 2)
Organization
Funding
CARB-X is funded by the Bill & Melinda Gates Foundation, Biomedical Advanced Research and Development Authority (BARDA), German Federal Ministry of Education and Research, National Institute of Allergy and Infectious Diseases (NIAID), United Kingdom Department of Health and Social Care (through the Global Antimicrobial Resistance Innovation Fund), and the Wellcome Trust.3)
Team
Global Accelerator Network
CARB-X's Global Accelerator Network is composed of:4)
1)
Robinson, J., & Finnegan, A. (2020, April 18). CARB-X funds Lytica Therapeutics to develop antibacterial peptides to treat drug-resistant infections in the lungs and other parts of the body. CARB-X. http://archive.today/2021.08.08-003713/https://carb-x.org/carb-x-news/carb-x-funds-lytica-therapeutics-to-develop-antibacterial-peptides-to-treat-drug-resistant-infections-in-the-lungs-and-other-parts-of-the-body/
2)
Hounsell, S. (2021, August 6). EXCLUSIVE: CDC Director Walensky’s Husband Received $5 Million in HHS Grants - and That’s Just the Start of It. RedState. https://web.archive.org/web/20230110204450/https://redstate.com/scotthounsell/2021/08/06/exclusive-cdc-director-walenskys-husband-received-5-million-in-hhs-grants-and-thats-just-the-start-of-it-n421809
3)
Funding Partners. (2022). CARB-X. http://archive.today/2022.06.06-075157/https://carb-x.org/partners/funding-partners/
4)
Global Accelerator Network. (2022). CARB-X. https://archive.ph/LXbx5